Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.0042 | 1 |
mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.0041 | 1 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.00051 | 1 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |
mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.0017 | 1 |
mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.00032 | 1 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.00032 | 1 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.00021 | 1 |